ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Hu B, Wiesehöfer M, de Miguel FJ, Liu Z, Chan LH, Choi J, Melnick MA, Arnal Estape A, Walther Z, Zhao D, Lopez-Giraldez F, Wurtz A, Cai G, Fan R, Gettinger S, Xiao A, Yan Q, Homer R, Nguyen DX, Politi K.
Hu B, et al. Among authors: liu z.
Cancer Res. 2024 Apr 15;84(8):1303-1319. doi: 10.1158/0008-5472.CAN-23-0438.
Cancer Res. 2024.
PMID: 38359163
Free PMC article.